Search This Blog

Friday, December 13, 2024

FDA Lifts Hold on BioNTech’s Key Cancer Trial

 

  • BioNTech’s FDA hold on its cancer trial was lifted.
  • Patient enrollment continues for squamous NSCLC in the trial.

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)